Oncotelic Therapeutics, Inc. (OTLC) — S-1 Filings
All S-1 filings from Oncotelic Therapeutics, Inc.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
Oncotelic S-1 Reveals Mast Hill to Resell 39.1% of Shares; Going Concern Doubts Persist
— Nov 21, 2025 Risk: high
Oncotelic Therapeutics, Inc. (OTLC) filed an S-1 on November 21, 2025, for the resale of 309,717,647 shares of common stock by Mast Hill Fund, LP, representing
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX